HOME >> BIOLOGY >> NEWS
Federal grant supports advances in infant heart disease at Children's Hospital of Philadelphia

Under a new federal initiative to foster "bench to bedside" studies, The Children's Hospital of Philadelphia has received a five-year grant from the National Heart, Lung and Blood Institute (NHLBI) for a coordinated research program in the causes and treatments of heart disease in children. Children's Hospital will receive $3.8 million in the first year of the grant, with the Hospital's five-year total estimated at more than $19 million.

Children's Hospital is one of four centers nationwide that the NHLBI has designated a Specialized Center of Clinically Oriented Research (SCCOR) in Pediatric Heart Development and Disease. The Institute's SCCOR program is a new initiative designed to speed the process by which advances in basic scientific knowledge are translated into innovative treatments for patients.

Pediatric cardiologist Robert J. Levy, M.D., is the principal investigator of the SCCOR program at Children's Hospital, entitled, "Genetic Mechanisms in Pediatric Heart Disease." The SCCOR award builds on an existing, very robust pediatric cardiology program at the hospital. The Cardiac Center at Children's Hospital is among the nation's largest and most comprehensive clinical programs in pediatric cardiology, cardiac surgery and cardiac anesthesia. The Cardiac Center's research program has become a major focal point both nationally and internationally for investigating the genetic basis of congenital heart disease.

"Over the past decade, investigators at Children's Hospital have made a series of discoveries supporting the hypothesis that congenital heart abnormalities are caused by gene defects," said Dr. Levy. "The new SCCOR grant will seek to transform our fundamental hypothesis into a translational approach that yields practical treatments."

Congenital heart abnormalities, which occur in approximately one in 100 live births, are the largest contributor to deaths from birth defects. Although advances in medical and sur
'"/>

Contact: John Ascenzi
Ascenzi@email.chop.edu
267-426-6055
Children's Hospital of Philadelphia
17-Feb-2004


Page: 1 2 3

Related biology news :

1. ORNL earns four Federal Laboratory Consortium awards
2. Federal government makes final call for data, public comment before writing new report on cancer-causing substances
3. Federally Sponsored Panel To Look At Data On Plasticizers: Do They Harm Reproduction, Or Childrens Development?
4. Science Article Criticizes Federal Policy Regarding Lead Exposure And Childrens Health
5. Federal Food Aid Makes Healthier Children
6. Pacific Northwests High-Tech Industry Faces Uncertain Future Under Proposed Cuts To Federal R&D Programs
7. UT Southwestern receives $1.78 million grant for obesity research as part of NIH Roadmap initiative
8. Schepens Eye Research Institute receives Roadmap grant to develop center for curing eye diseases
9. Florida Tech earns $50,000 grant to create coral database
10. $7.5 Million grant to Yale researchers for role of viruses in cancer
11. Northeastern University receives $12.4 million NSF grant for creation of nanomanufacturing institute

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/21/2020)... Calif. (PRWEB) , ... August 19, 2020 , ... ... both Salimetrics LLC and SalivaBio LLC, businesses dedicated to Salivary Bioscience for more ... of the recently published book by Springer, " Salivary Bioscience: Foundations of Interdisciplinary ...
(Date:8/12/2020)... ... 2020 , ... Mosio recently announced its newly updated text ... of all sizes. With a focus on tracking symptoms and monitoring outbreaks as ... Mosio helps public health departments automate communications and provide more personalized care and ...
(Date:8/3/2020)... ... 03, 2020 , ... Accumen Inc. is helping healthcare get ... Spectrum Solutions, to provide COVID-19 saliva testing kits nationally. , “Accumen has ... than 10 years. Early in the COVID-19 crisis, we identified supply chain gaps ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... ... August 11, 2020 , ... ... firm, is making available for free its new white paper – Simulated ... simulation testing into today’s biologics licensing application (BLA). In response, Modality Solutions ...
(Date:7/31/2020)... ... ... R3 Stem Cell International is now offering patients the opportunity to receive four ... may choose which extremities they would like treated. , Several studies have shown just ... R3 International, umbilical cord tissue is obtained from a lab with a long history ...
(Date:7/31/2020)... ... July 29, 2020 , ... eSource has long been touted ... will cover the history of eSource, the reasons it did not take off as ... to site source, the industry is moving towards capturing data electronically for clinical trials ...
(Date:7/18/2020)... (PRWEB) , ... July 16, 2020 , ... “We are ... Third Wave Bioactives. “It’s the only technology of its kind on the market and ... of onions with the protective capacity of traditional cultured ingredients, creating a natural way ...
Breaking Biology Technology:
Cached News: